148 related articles for article (PubMed ID: 6257480)
1. Bone collagen synthesis in vitro: structure/activity relations among parathyroid hormone fragments and analogs.
Bringhurst FR; Potts JT
Endocrinology; 1981 Jan; 108(1):103-8. PubMed ID: 6257480
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of a potent synthetic analog of bovine parathyroid hormone with native bPTH-(1-84) and synthetic bPTH-(1-34) on bone resorption and collagen synthesis.
Raisz LG; Lorenzo J; Gworek S; Kream B; Rosenblatt M
Calcif Tissue Int; 1979; 29(3):215-8. PubMed ID: 117885
[TBL] [Abstract][Full Text] [Related]
3. The arterio-venous difference for immunoreactive parathyroid hormone and the production of adenosine 3,'5'-monophosphate by isolated perfused bone: studies with analogs of parathyroid hormone.
Martin KJ; Bellorin-Font E; Freitag J; Rosenblatt M; Slatopolsky E
Endocrinology; 1981 Sep; 109(3):956-9. PubMed ID: 6266817
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for parathyroid hormone action in mature bone. Effects on release of cyclic adenosine monophosphate and bone gamma-carboxyglutamic acid-containing protein from perfused rat hindquarters.
Calvo MS; Fryer MJ; Laakso KJ; Nissenson RA; Price PA; Murray TM; Heath H
J Clin Invest; 1985 Dec; 76(6):2348-54. PubMed ID: 3001148
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of parathyroid hormone: relative sensitivity of rabbit renal microvessel and tubule adenylate cyclases to oxidized PTH and PTH inhibitors.
Helwig JJ; Yang MC; Bollack C; Judes C; Pang PK
Eur J Pharmacol; 1987 Aug; 140(3):247-57. PubMed ID: 2820761
[TBL] [Abstract][Full Text] [Related]
6. Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin.
Dietrich JW; Canalis EM; Maina DM; Raisz LG
Endocrinology; 1976 Apr; 98(4):943-9. PubMed ID: 945152
[TBL] [Abstract][Full Text] [Related]
7. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2.
Goldman ME; McKee RL; Caulfield MP; Reagan JE; Levy JJ; Gay CT; DeHaven PA; Rosenblatt M; Chorev M
Endocrinology; 1988 Nov; 123(5):2597-9. PubMed ID: 2844517
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of parathyroid hormone by fetal rat calvaria.
Freitag JJ; Martin KJ; Conrades MB; Slatopolsky E
Endocrinology; 1979 Feb; 104(2):510-6. PubMed ID: 221182
[TBL] [Abstract][Full Text] [Related]
9. Effects of synthetic analogs and fragments of bovine parathyroid hormone on adenosine 3',5'-monophosphate level, ornithine decarboxylase activity, and glycosaminoglycan synthesis in rabbit costal chondrocytes in culture: structure-activity relations.
Takano T; Takigawa M; Shirai E; Suzuki F; Rosenblatt M
Endocrinology; 1985 Jun; 116(6):2536-42. PubMed ID: 2986953
[TBL] [Abstract][Full Text] [Related]
10. Biological activities of synthetic human parathyroid hormone (PTH) 1-84 relative to natural bovine 1-84 PTH in two different in vivo bioassay systems.
Zanelli JM; Lane E; Kimura T; Sakakibara S
Endocrinology; 1985 Nov; 117(5):1962-7. PubMed ID: 2995003
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of various lengths of synthetic human parathyroid hormone-related peptide (hPTHrP) of malignancy on bone resorption and formation in organ culture.
Pilbeam CC; Alander CB; Simmons HA; Raisz LG
Bone; 1993; 14(5):717-20. PubMed ID: 8268045
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of synthetic human parathyroid hormone (PTH)-(1-34)-related peptide of malignancy and bovine PTH-(1-34) on bone formation and resorption in organ culture.
Klein-Nulend J; Fall PM; Raisz LG
Endocrinology; 1990 Jan; 126(1):223-7. PubMed ID: 2293986
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of in vitro bone resorption by a parathyroid hormone receptor antagonist in the canine adenocarcinoma model of humoral hypercalcemia of malignancy.
Rosol TJ; Capen CC
Endocrinology; 1988 May; 122(5):2098-102. PubMed ID: 2834184
[TBL] [Abstract][Full Text] [Related]
14. Human parathyroid hormone (PTH)-related protein and human PTH: comparative biological activities on human bone cells and bone resorption.
Fukayama S; Bosma TJ; Goad DL; Voelkel EF; Tashjian AH
Endocrinology; 1988 Dec; 123(6):2841-8. PubMed ID: 2848688
[TBL] [Abstract][Full Text] [Related]
15. Metabolism and biological activity of parathyroid hormone in renal cortical membranes.
Goltzman D; Peytremann A; Callahan EN; Segre GV; Potts JT
J Clin Invest; 1976 Jan; 57(1):8-19. PubMed ID: 173743
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of parathyroid hormone analogs in the opossum kidney cell line.
Cole JA; Carnes DL; Forte LR; Eber S; Poelling RE; Thorne PK
J Bone Miner Res; 1989 Oct; 4(5):723-30. PubMed ID: 2554688
[TBL] [Abstract][Full Text] [Related]
17. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
[TBL] [Abstract][Full Text] [Related]
18. Binding of intact parathyroid hormone to rat osteosarcoma cells: major contribution of binding sites for the carboxyl-terminal region of the hormone.
Rao LG; Murray TM
Endocrinology; 1985 Oct; 117(4):1632-8. PubMed ID: 2992916
[TBL] [Abstract][Full Text] [Related]
19. Structure-function relationship studies of bovine parathyroid hormone [bPTH(1-34)] analogues containing alpha-amino-iso-butyric acid (Aib) residues.
Peggion E; Mammi S; Schievano E; Schiebler L; Corich M; Rosenblatt M; Chorev M
Biopolymers; 2003 Mar; 68(3):437-57. PubMed ID: 12601801
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of second messenger activation by parathyroid hormone fragments in osteosarcoma cells.
Fujimori A; Cheng SL; Avioli LV; Civitelli R
Endocrinology; 1991 Jun; 128(6):3032-9. PubMed ID: 1645259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
